FDA warns Curaleaf about inflated claims in CBD product marketing
4 years ago
32
A major medical marijuana company is under fire from the FDA. The agency sent Curaleaf a letter of warning over concerns that the cannabis company is marketing some of its products containing CBD as being effective treatments for cancer, Alzheimer's disease, opioid withdrawal and pain.
Loading comments...
-
2:11
WFTX
8 months agoDebris, bacteria in SWFL water after Idalia
317 -
0:42
KMGH
2 years agoBBB warns about travel scams
45 -
0:43
KMGH
2 years agoBBB warns about counterfeit items
44 -
0:53
KMGH
2 years agoBBB warns about weight loss supplements
11 -
1:14
Reuters
2 years agoWHO warns about Ukraine's 'humanitarian catastrophe'
158 -
0:41
KMGH
2 years agoBBB warns about crypto message on Instagram
31 -
1:58
WFTS
2 years agoFBI warns about popular Facebook scam
83 -
LIVE
Right Side Broadcasting Network
3 days agoLIVE: President Trump Keynotes Minnesota GOP Annual Dinner - 5/17/24
27,182 watching -
LIVE
Laura Loomer
1 hour agoEP47: Georgia GOP Rocked With Anti-Trump Scandal Ahead of State RNC Convention
1,752 watching -
LIVE
Roseanne Barr
2 hours agoWe finally got Ryan Long!!!! | The Roseanne Barr Podcast #48
3,541 watching